修改的PECS II区块用于下腺炎Suppurativa
Michael Shalaby1, Raghav Sahni2, Daniel Puebla3
1Herbert Wertheim College of Medicine at Florida International University, Miami, Florida; Department of Emergency Medicine, Mount Sinai Medical Center, Miami Beach, Florida.
The Journal of emergency medicine
|May 18, 2024
概括
经过修改的PECS II阻断为管理需要切割和排水的腹炎 (HS) 恶化提供了一个不那么痛苦的解决方案. 这种技术有效地麻醉了下,消除了直接注射局部麻醉剂到痛苦的HS病变的需要.
科学领域:
- 麻醉学 麻醉学
- 皮肤病学 皮肤病学
- 疼痛管理 疼痛管理
背景情况:
- 补腺炎 (HS) 是一种慢性炎症性皮肤疾病,导致疼痛恶化.
- 患者经常需要急诊室的访问,以切割和排水HS病变.
- 在HS手术中直接注射局部麻醉剂是非常痛苦的,并且往往不充分.
研究的目的:
- 为了评估在HS患者中用于尾麻醉的修改后的PECS II块.
- 为了减少切口和排水过程中的手术疼痛,HS.
主要方法:
- 改进的胸部壁外科手术 (PECS) 的修改后的胸部阻塞II阻塞技术被采用.
- 修改后的区块只需要进行传统PECS II区块的第二次注射.
- 一个双边修改的PECS II阻断被施用给一个正在进行切口和疏通的双边头HS病变的患者.
主要成果:
- 经过修改的PECS II块成功地给下部提供了麻醉.
- 患者在切口和排水过程中不需要额外的局部麻醉.
- 这项程序在患者的疼痛显著减少的情况下得到了管理.
结论:
- 修改后的PECS II阻断是一种潜在的有效方法,用于HS患者的尾麻醉.
- 这种技术可以使HS恶化的管理变得不那么痛苦.
- 它提供了一个可行的替代方案,直接注射局部麻醉剂.
相关概念视频
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease I: Introduction
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...


